Aging And Precision Medicine Will Drive Specialty Markets Amid Risks
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
16 Jul 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$67.00
38.1% undervalued intrinsic discount20 Aug
US$41.50
1Y
232.5%7D
5.0%